🔎 Trials Near Me

ホーム › 過体重 › イリノイ州 › Chicago

Chicago、ILにおける過体重の臨床試験

Chicagoとその周辺地域(約30マイル以内)の拠点で、過体重に関する28件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。

公式研究テキスト(英語)

ここで研究参加者を募集していますか? このページの上部に表示できます — 30日間 $99 →

Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities

被験者募集中第2相
  • Great Lakes Clinical Trials - West Wilson Avenue /ID# 282378, Chicago
18歳〜75歳 · 全性別 · 2026/10/01更新 · NCT07752979

Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes

被験者募集中第2相
  • Charter Research LLC - Chicago, Chicago
  • Flourish Research - Chicago, Chicago
18歳以上 · 全性別 · 2026/09/29更新 · NCT07685808

AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight

被験者募集中第3相
  • Great Lakes Clinical Trials, Chicago
18歳以上 · 全性別 · 2026/09/28更新 · NCT07720271

A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide

被験者募集中第3相
  • Chicago Research Center, Inc, Chicago
18歳以上 · 全性別 · 2026/09/28更新 · NCT07668414

A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity

被験者募集中第3相
  • Great Lakes Clinical Trials - Ravenswood, Chicago
18歳以上 · 全性別 · 2026/09/28更新 · NCT07794579

A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity

被験者募集中第3相
  • Cedar Crosse Research Center, Chicago
  • Northwestern University, Chicago
18歳以上 · 全性別 · 2026/09/28更新 · NCT07595549

A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)

被験者募集中第3相
  • Ann and Robert Lurie Children's Hospital of Chicago, Chicago
  • University of Illinois at Chicago, Chicago
6歳〜17歳 · 全性別 · 2026/09/24更新 · NCT06672549

Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

被験者募集中第3相
  • Rush University Medical Center, Chicago
18歳〜70歳 · 全性別 · 2026/09/24更新 · NCT06937099

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

被験者募集中第3相
  • Rush University Medical Center, Chicago
18歳〜70歳 · 全性別 · 2026/09/24更新 · NCT06937086

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

被験者募集中第3相
  • Eagle Clinical Research, Chicago
  • University of Chicago, Chicago
45歳〜99歳 · 全性別 · 2026/09/22更新 · NCT07037433

A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin

被験者募集中第3相
  • Great Lakes Clinical Trials - Ravenswood, Chicago
18歳以上 · 全性別 · 2026/09/22更新 · NCT07392190

A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight

被験者募集中第2相
  • Great Lakes Clinical Trials - Ravenswood, Chicago
18歳〜75歳 · 全性別 · 2026/09/22更新 · NCT07589608

Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight

被験者募集中第3相
  • Great Lakes Clinical Trials - Ravenswood, Chicago
18歳以上 · 全性別 · 2026/09/22更新 · NCT07353931

A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight

被験者募集中第3相
  • Research Site, Chicago
18歳以上 · 全性別 · 2026/09/22更新 · NCT07784270

A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight

被験者募集中第2相
  • Great Lakes Clinical Trials - Ravenswood, Chicago
18歳〜75歳 · 全性別 · 2026/09/08更新 · NCT06143956

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)

被験者募集中第3相
  • Flourish Research - Great Lakes Clinical Trials, Chicago
18歳〜99歳 · 全性別 · 2026/09/03更新 · NCT07684235

BRIDGE & Friends Trial

被験者募集中健康なボランティア歓迎
  • University of Illinois Chicago, Chicago
50歳〜79歳 · 全性別 · 2026/09/01更新 · NCT07798557

Assess the Effects of Replacing Foods High in Refined Carbohydrates With Avocado on Biomarkers of Inflammation.

被験者募集中健康なボランティア歓迎
  • Illinois Institute of Technology, Chicago
21歳〜74歳 · 全性別 · 2026/08/27更新 · NCT07566325

A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus

被験者募集中第3相
  • Research Site, Chicago
18歳以上 · 全性別 · 2026/08/25更新 · NCT07784725

Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)

被験者募集中第3相
  • ACCOMPLISH-1 Research Site, Chicago
18歳〜79歳 · 全性別 · 2026/08/10更新 · NCT07654361

Functional Improvement in OSA and COPD With a Telehealth LifeStyle and Exercise Intervention

被験者募集中
  • Jesse Brown VA Medical Center, Chicago
18歳以上 · 全性別 · 2026/07/22更新 · NCT06390345

FIM+DASH: Food is Medicine Intervention to Promote Healthy Eating and Blood Pressure Control

被験者募集中第2相
  • Mile Square Health Center Chicago, Chicago
  • Mile Square Health Center - Auburn Gresham, Chicago
  • Mile Square Health Center - Englewood, Chicago
  • 他1件
全年齢 · 全性別 · 2026/07/10更新 · NCT07332741

Better Lifestyle Counseling for African American Women During Pregnancy

被験者募集中
  • University of Illinois at Chicago, Chicago
  • University of Illinois at Chicago, Chicago
18歳〜40歳 · 女性 · 2026/07/09更新 · NCT05234125

People With Multiple Sclerosis Treated With Ocrelizumab and GLP-1 Agonists

被験者募集中観察研究
  • Northwestern Memorial Hospital, Chicago
18歳〜70歳 · 全性別 · 2026/03/17更新 · NCT07207148

Semaglutide for Metabolic Intervention and Adipose Loss to Treat Atrial Fibrillation

被験者募集中第3相
  • University of Chicago, Chicago
18歳〜75歳 · 全性別 · 2025/11/14更新 · NCT06499857

他の都市における過体重の試験

Chicagoにおける他の研究

ClinicalTrials.govより、2026/10/02時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。